DMAC·25253X207·US·equity·Healthcare - Biotechnology-13D/G
DMAC (DIAMEDICA THERAPEUTICS INC) is held by 63 institutional investors as of Q4 2025. Largest holders: COOPERMAN LEON G ($16.1M), BlackRock, Inc. ($15.1M), MILLENNIUM MANAGEMENT LLC ($6.1M). Net institutional sentiment: Mixed.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer